Application of Mammary Gland Endoprosthesis without a Shell in Modern Oncomammological Practice


Immediate and late follow-up results of oncomammological application of novel Ukrainian endoprosthesis “Nubiplant”, made of one piece of polyacrylamide gel, for mammary gland malignancies (MGM) radical treatment with reconstruction were analyzed. This endoprosthesis have proved its unique complex of favorable surgical and oncological properties, such as the shape and size accommodation for mammary gland plasty purposes, absence of shell and textured surface. Of 184 patients, operated on radically for initial stages of MGM, using "Nubiplant" endoprosthesis, postoperative complications have had occur in 18 (9,8%): the wound seroma in 12 (6,5%) and partial necrosis of cutaneous edge of postoperative wound – in 6 (3,8%). The seromas were successfully treated by their punctures and local necrosis - using excision with secondary suture placement. Late follow-up results were obtained in 112 (60,9%) patients: three-year period have had survived 104 (92,6±2,4%), and a five-year one – 84 (75,0±4,0%) of them. A contracture capsule was revealed in 3 (2,6%) patients, and excised with the endoprosthesis change. “Nubiplant” endoprosthesis have advantages over most popular worldwide kinds of such products. It may be used securely and effectively for total or partial reconstruction of mammary gland, including cases with hypoplasia, and is more resistant to trauma, radiation therapy and local complications occurrence, including contracture capsule formation. Its property to absorb the water may be used for purposes of plastic surgery. Prophylaxis of specific immediate surgical complications is trustworthy in MGM patients, using modified endoprosthesis “Nubiplant”, containing insulin, antihistamine and antiseptic medicines.

Share and Cite:

S. Myasoyedov, D. Myasoyedov and P. Moiseyev, "Application of Mammary Gland Endoprosthesis without a Shell in Modern Oncomammological Practice," Engineering, Vol. 4 No. 10B, 2012, pp. 72-75. doi: 10.4236/eng.2012.410B019.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] V. F. Semiglazov, S. G. Petrovskiy, and S. V. Kanayev, “Modern approaches to the treatment of mammary gland cancer,” Voprosy oncologii, 2004, № 1, pp. 114-115.
[2] R. Miller,”Estrogen and breast cancer,” in Cancer of Mammary Gland, Grandess Co., Austin (USA), 1996, P. 207.
[3] Z. P. Fedorenko, A. V. Gaysenko, and L I.Gulak, “Cancer in Ukraine in 2008-2009,” Bulletin of National cancer registry of Ukraine, Kyiv, 2010, № 11, P. 110
[4] N. N. Volchenko, “Morphological factors of prognosis in mammary gland cancer,” Russian oncological journal, 2000, № 3, pp. 49-52
[5] D. D. Pak and E. A. Rasskazova, “Organpreserving operations in mammary gland cancer,” 2011, № 5, pp. 10-14.
[6] A. Shi, D. Wu, X. Li, S. Zhang, S. Li, H. Xu, H. Xie, and Z. Fan, “Subcutaneous Nipple-sparing Mastectomy and Immediate Breast Reconstruction // Breast Care (Basel), 2012, Vol. 7, № 2, рр. 131-136
[7] J. D. Yang, J. W. Lee, W. W. Kim, S. O. Hwang, J. H. Jung, and H. Y. Park,“Surgical techniques for personalized oncoplastic surgery in breast cancer patients with small-to-moderate sized breasts (part 2) volume replacement // J Breast Cancer, 2012, Vol. 15, № 1, pp. 7-14
[8] S. D. Myasoyedov, Ya. A. Tersenov, and P. S. Moiseyev, “About indications for conduction of subcutaneous mastectomy with simultaneous endoprosthesis in patients, suffering mammary gland cancer,”in “The Works of XIIth Congress of oncologists of Ukraine,” [Digests 12th Congress of oncologists of Ukraine, Sudak, Crimea, p. 102, 2010].
[9] D. V. Myasoyedov, and P. S. Moiseyev, “Mammary gland endoprosthesis “Nubiplant”, made of polyacrylamide gel”, unpublished.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.